Real-World Effectiveness and Safety of Isavuconazole Versus Amphotericin B for Patients with Invasive Mucormycosis
Background: Invasive mucormycosis (IM) poses a substantial morbidity and mortality burden among immunocompromised patients. Objectives: We aim to compare the real-world effectiveness and safety of isavuconazole with those of amphotericin B in patients with IM. Patients and methods: In this observati...
Saved in:
Main Authors: | Jiayuan Qin, Hongxia Bi, Guangmin Tang, Xinyao Liu, Junyan Qu, Xiaoju Lv, Yanbin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/13/1/55 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sinonasal mucormycosis with an unusual involvement of palate
by: Santosh Kumar Swain
Published: (2022-01-01) -
Pulmonary Mucormycosis – An Experience from a Tertiary Care Center in Southern India: A PULM MUCOR Study
by: Ashwin Oliver Arul, et al.
Published: (2025-01-01) -
Appendiceal Perforation and Abdominal Wall Infection Caused by Invasive Mucormycosis in a Child with Acute Leukemia
by: Li C, et al.
Published: (2025-01-01) -
Evaluation and testing of polymethylmetacrylic (PMMA) bone cements with admixed Amphotericin B
by: Florian A. Frank, et al.
Published: (2025-02-01) -
Effects of fluconazole and amphotericin B in the control of cryptococcal pneumonia in vivo
by: Zhao Yu, et al.
Published: (2025-01-01)